---
schema_version: "secwatch.filing_event.v1"
accession: "0001510964-22-000085"
form_type: "8-K"
ticker: "CVSI"
cik: "0001510964"
company_name: "CV Sciences, Inc."
filed_at: "2022-11-14T23:59:59+00:00"
generated_at: "2026-06-21T20:01:34.992511+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CV Sciences Q3 2022 revenue down 27% YoY to $3.8M, operating loss narrowed to $0.9M

## Summary
- Revenue $3.8M, down 27% from $5.1M; gross margin 41.6% vs 46.2%.
- Operating loss improved to $0.9M from $3.0M; negative adjusted EBITDA $1.2M vs $2.7M.
- Cash balance $1.1M; extinguished entire outstanding convertible debt.
- Preliminary approval of settlement of six shareholder derivative lawsuits; continues strategic review including M&A.
- Launched PlusCBD Reserve Collection; maintains #1 hemp extract brand in natural channel per SPINS.

## SEC filing metadata
- accession: 0001510964-22-000085
- form_type: 8-K
- ticker: CVSI
- cik: 0001510964
- company_name: CV Sciences, Inc.
- filed_at: 2022-11-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1510964/000151096422000085/0001510964-22-000085-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1510964/000151096422000085/cvsi-20221114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001510964-22-000085
- JSON: https://secwatch.observer/filing/0001510964-22-000085.json
- Plain text: https://secwatch.observer/filing/0001510964-22-000085.txt

## Key facts
- Earnings Releases
  CV Sciences, Inc. reported the quarter ended September 30, 2022 results: revenue $3.8 million.
  - Period: the quarter ended September 30, 2022
  - Revenue: $3.8 million
  - Result: reported results
  source text: today announced its financial results for the quarter ended September 30, 2022. Third Quarter 2022 and Recent Financial and Operating Highlights • Revenue of $3.8 million for third quarter of 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1510964/000151096422000085/0001510964-22-000085-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.